"13:05: Turning now to the BLA for HIV, During the

New Post Public Reply Private Reply Replies (2) Message Board
MGK_2
753


Quote:
"13:05: Turning now to the BLA for HIV, During the course of last few months, we have had the chance to get a much clearer look at the state of the clinical data collected by Amarex . This showed us to perform an internal feasibility assessment, on the clinical portion of the BLA, With a key question of understanding, if the data would withstand , what is commonly referred to as a good clinical practice, or a GCP audit, which is precisely what we would expect the FDA to perform during the BLA review Process. And as a result of our internal assessment, we decided to perform external audit of that same data and we expect to receive those results of that audit in near term. And those results will inform our next steps with the BLA. I want to make clear, that this audit is not a question of the performance of Leronlimab in clinical trials . Rather, it is an assessment of the quality of the data collection and monitoring performed by Amarex . And We are performing this purely To assess the probability that if the BLA submission had been completed, that it would pass an FDA type GCP audit ."


And this goal, to assess the quality of the data collection and monitoring performed by Amarex is coming to light. And the determination of the probability that had the submission of the BLA for HIV been completed, would it have passed an FDA Type GCP, Good Clinical Practice Audit is being summed up . And we have received the answer today, and that answer is a resounding, NO. These FDA External Enforcing Auditors are by far and wide, completely taking Amarex by storm and by surprise . Operation Storm. They are being looked at from every which angle, and every last nuance of delinquency is being discovered and brought to light. Amarex thought they were above the law. Yeah, maybe when there was no law. But Cyrus brought the law to them. And the Enforcer is getting it done . The Investigator's Brochure has been submitted , the Warning Banner Removed, the ISS and ISE (Integrated Summaries of Safety and Effectiveness) are done and submitted according to FDA Type GCP format. Without an OK from the External Auditor, CytoDyn would not have submitted these documents, and that is proof that the data has been aggregated by CytoDyn's Internal Audit Committee in accordance with GCP format . Last week, a tangential law suit gets dismissed? These Auditors are working magic for CytoDyn, I mean havoc for Amarex. Amarex won't get dismissed because, CytoDyn is the Plantiff . Amarex is getting the handcuffs. Are they squirming yet? Pissing in their pants yet? Can't sleep at night Amarex? Who's coming to your side Amarex, to your aid? Those who paid you? to get you to commit your dirty deeds of sabotage upon CytoDyn and Leronlimab? Are you going to implicate them to get your self out? No? Are you going to tell them you are in trouble?, so they can make more trouble for CytoDyn before the judgement hammer falls?, so that possibly you can escape? Not. You're in deep shit Amarex. Quick sand even. You can't move in quick sand Amarex, you just keep sinking and sinking and you can't breathe. You better get your ass in gear if you want to see another day. But that ain't happening. You got friends who paid you? Now is the time to act. Go ahead. Let's see if you want to play the game of Diversion. Let's see.

Patience folks...

Hang in there.

Slowly but surely, we are getting there. Monday should be interesting...

https://www.reddit.com/r/LeronLimab_Times/com...;context=3
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sustainability 2026: Action Beyond Conference Halls

Updated Category News Views 104

Carbon-Neutral Promises: Walking the Walk Forget endless talk—Shanghai's 2026 Sustainability Global Leaders Conference hammered home that actions need to spill over beyond the plush conference seats every single attendee warmed. We're not talking about token efforts either; they ensured the gathering itself was carbon-neutral. That's practicing what you preach with a...

Continue Reading
Bram Schot Steers Marelli Through Chapter 11 Resurgence

Updated Category News Views 105

So, Marelli's rolling out the heavy artillery with the appointment of Bram Schot as their future Chair. This isn't just reshuffling a few chairs on the deck of a wobbly ship. No, Marelli's emergence from Chapter 11, with Schot at the helm, is more akin to a full-blown course correction. The man comes seasoned, having braved the corporate gales at Audi, Mercedes-Benz, and...

Continue Reading
Jury Awards $29M in Landmark School Abuse Case

Updated Category News Views 86

California Schools Face Scrutiny Over Abuse Verdict Some days, the gavel falls, and its echo shakes up more than just a courtroom. That’s exactly what we’re seeing with this hefty $29 million verdict against ABC Unified School District. It’s not just a payout; it’s a bombshell that could change the landscape for how schools handle allegations of abuse. $29 Million...

Continue Reading
CorelDRAW PowerTRACE: Fast, Precise Vector Conversion

Updated Category News Views 43

Expert Consumers Spotlight CorelDRAW PowerTRACE Ah, the humble art of converting blurry bitmaps into crisp vectors—a task plenty have fumbled through with countless late nights and missed deadlines. But here's a kicker: CorelDRAW PowerTRACE seems to be setting new standards in bitmap-to-vector conversions this year, grabbing attention with some pretty spiffy upgrades...

Continue Reading
Ast?'s Strategy: Scaling Brands with Operator Insight

Updated Category News Views 44

Defining the Investor-Entrepreneur Partnership Ah, building a consumer brand is no walk in the park, but what about scaling it? Here's where the rubber really meets the road. Enter Ast? Consumer Partners, a firm that clearly understands that scaling a brand isn't all about throwing cash at it—it’s about precision and the right mix of wisdom, much like a seasoned chef...

Continue Reading
Key Life Events That Demand a Financial Plan Change

Updated Category News Views 39

Navigating Life's Milestones with Financial Savvy Nothing stirs the financial pot quite like life's big events. The grind of daily life might trick you into thinking everything's fine, but ignore these milestones at your peril. Ted Thatcher, a financial advisor from Roseville, California, lays it out in HelloNation's latest foray into sound financial planning: your...

Continue Reading
Qfin Faces Stock Lawsuit: Know Your Investor Rights

Updated Category News Views 129

Qfin in the Legal Hot Seat When you hear about a company's legal wranglings, especially one like Qfin Holdings, Inc., you've got to sit up and take notice. We're not talking about a quick scuffle here; this is a full-blown class action lawsuit with its talons sunk deep into allegations of securities law violations. They're squared off against DJS Law Group, an outfit that...

Continue Reading
GAC Hits Record with 223,000 Units Exported in 2026

Updated Category News Views 88

GAC Gaining Ground Globally in 2026 China's GAC is making waves with its recent export figures. They've blitzed past the competition, exporting 223,000 units from January to October 2026. That's not just a number, it’s a record, with October alone seeing a hefty 26,017 units shipped—marking an impressive 80.8% growth compared to last year. A Strategic Push in Europe...

Continue Reading
Aries Ignites a Social Renaissance in La Jolla

Updated Category News Views 58

The Dawn of Aries: A Beacon for Social Change Coming out of nowhere, Aries is set to make waves in La Jolla, and no, I'm not talking about another swell hitting the shores. Instead, we're witnessing a new chapter for the rooftop of Hotel La Jolla, where an investment of over a cool million bucks aims to deliver a slice of European flare right here on the Pacific. A...

Continue Reading
'Dedicate' Series Arrives on Prime, Tapping Global Heartstrings

Updated Category News Views 102

An Unconventional Hit Finds a New Home Kick back for a second, because this ain't just another series buried under the deluge of shows streaming these days. Nope, this is about 'Dedicate,' a joint of its own unique flavor that's now nabbed a spot on Prime Video. It's not like we're talking about the latest Hollywood blockbuster here—it's a series brought to you by The...

Continue Reading

Top 5 Most Recently Viewed Articles

Navigating Tesla's Market Dynamics Ahead of Earnings Reveal

Updated Category News Views 96

Understanding Tesla's Current Market Position Tesla Inc's stock, identified by the ticker TSLA, is approaching a critical moment with its third-quarter earnings expected to be announced after market hours on an upcoming Wednesday. Investors are keenly watching how the company's performance will unfold, especially given the notable price trends observed year-to-date....

Continue Reading
Dustin Bass Joins ENA Leadership in Strengthening Nursing Bonds

Updated Category News Views 89

Dustin Bass Begins His Journey as ENA President The 2026 president of the Emergency Nurses Association (ENA), Dustin Bass, is eager to embark on a significant year for emergency nursing. His passion revolves around uniting members of the ENA and fostering a sense of belonging within the emergency nursing community. With over 40,000 members, the ENA plays a crucial role in...

Continue Reading
New York Medicaid Embraces TMS Therapy for Depressive Disorders

Updated Category News Views 211

Expansion of TMS Therapy Coverage by New York Medicaid MALVERN, Pa. — Neuronetics, Inc. (NASDAQ: STIM), a prominent medical technology company dedicated to enhancing the quality of life for those with neurohealth disorders, has exciting news. The state of New York has decided to expand Medicaid coverage to include Transcranial Magnetic Stimulation (TMS) therapy for...

Continue Reading
Essential Financial Planning Tips for 2024

Updated Category Personal Finance Views 779

In an era marked by rapid technological advancements and unpredictable economic landscapes, financial planning has emerged as a crucial skill set, especially for Millennials, Gen Z, and young professionals. With 2024 on the horizon, understanding how to effectively manage your finances is more important than ever. This comprehensive guide will walk you through the...

Continue Reading
Understanding the Latest Developments in Neumora Therapeutics Lawsuit

Updated Category News Views 210

Leading the Charge: Neumora Therapeutics Investor Lawsuit Stockholders of Neumora Therapeutics, Inc. (NASDAQ: NMRA) are now facing a pivotal moment as a class action lawsuit emerges. With potential legal avenues for recourse, it’s essential for investors to be informed about their rights and what they need to do next. Understanding Class Action Lawsuits A class action...

Continue Reading